Determinants of Quality of Life in Myasthenia Gravis Patients

Background: Although approximately half of myasthenia gravis (MG) patents achieve remission, for the remaining group MG is often a life-long disease. Better understanding of the determinants of Quality of Life (QoL) in MG is needed to optimize treatment goals in chronic cases.Materials and Methods:...

Full description

Bibliographic Details
Main Authors: Piotr Szczudlik, Ewa Sobieszczuk, Beata Szyluk, Marta Lipowska, Justyna Kubiszewska, Anna Kostera-Pruszczyk
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.553626/full